Literature DB >> 27303060

Immunoassay interference complicating management of Cushing's disease: the onus is on the clinician and the laboratory.

Kay W Choy1, Jessie Teng2, Nilika Wijeratne1,3,4, Chin Y Tan2, James Cg Doery1,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27303060     DOI： 10.1177/0004563216657362

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN： 0004-5632            Impact factor:   2.057


× No keyword cloud information.
  4 in total

1.  Interference in ACTH immunoassay negatively impacts the management of subclinical hypercortisolism.

Authors:  Serkan Yener; Leyla Demir; Mustafa Demirpence; Mustafa Mahmut Baris; Ilgin Yildirim Simsir; Secil Ozisik; Abdurrahman Comlekci; Tevfik Demir
Journal:  Endocrine       Date:  2017-02-28       Impact factor: 3.633

2.  When laboratory tests can mislead even when they appear plausible.

Authors:  Adel Aa Ismail
Journal:  Clin Med (Lond)       Date:  2017-07       Impact factor: 2.659

3.  Heterophile Antibody to Adrenocorticotropin Hormone Interfering with the Investigation of Cushing's Syndrome.

Authors:  Adam Morton; Tom Dover
Journal:  Indian J Clin Biochem       Date:  2018-06-16

Review 4.  Hormone Immunoassay Interference: A 2021 Update.

Authors:  Khaldoun Ghazal; Severine Brabant; Dominique Prie; Marie-Liesse Piketty
Journal:  Ann Lab Med       Date:  2022-01-01       Impact factor: 3.464
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.